Bet on Earnings, No...
Health Care: Drugs
Salix Pharmaceuticals Ltd. (SLXP: NASDAQ)
$66.72 -0.11 | -0.16%
06/19/13 - 10:00 AM ET
21.93K / 563.70K
Vol / Avg. Vol:67.26 / 66.83
Open / Prev. Close:66.57 - 67.38
Today's Range:37.52 - 68.62
52 Wk Range:63.60%
Performance YTD:TheStreet Rating:
Portfolios with SLXP
- Portfolio NameUser Type
- ContributorDrugs Facing FDA Approval i...
- User7 Stocks with Strong and St...
- ContributorBreakout Stocks Of The Week...
- ProDiscovery Capital Management
- ContributorBreakout Stocks Of The Week...
- Contributor10 Pharma Stocks With Upside
- Contributor10 Biotech Stocks Facing FD...
- UserTop Healthcare Short Squeez...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
Latest SLXP Headlines from TheStreet
- Salix Pharmaceuticals Ltd. Stock Upgraded (SLXP) 01.28.13 | 04:01 am
- FDA Places New Heart-Safety Hurdle in Path of Opioid Constipation Drugs 11.12.12 | 10:11 am
- Salix Pharmaceuticals Ltd. Stock Downgraded (SLXP) 11.09.12 | 04:11 am
- Nektar Therapeutics Is a Short 09.12.12 | 07:09 am
- Salix Pharmaceuticals Ltd. (SLXP): Today's Featured Health Care Laggard 08.27.12 | 05:08 pm
- Salix Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.10.12 | 07:08 pm
- 7 Most Reliable Growth Stocks in the Market 08.03.12 | 07:08 am
- Stocks Take Breather After Recent Surge 07.30.12 | 04:07 pm
- Salix Stock Hits New 52-Week High (SLXP) 07.02.12 | 09:07 am
- Salix Reaches New 52-Week High (SLXP) 06.19.12 | 10:06 am
Press Releases for SLXP
- Salix Pharmaceuticals Commits $1.125M To AGA Research Foundation - PR Newswire 03.13.13 | 09:03 am
- Salix Pharmaceuticals Reports 4Q2012 And FY2012 Results - Business Wire 02.28.13 | 04:02 pm
- Salix Pharmaceuticals To Present At Two Investment Conferences In March - Business Wire 02.25.13 | 01:02 pm
- Salix Pharmaceuticals Announces 4Q2012 And FY2012 Financial Results Conference Call And Webcast - Business Wire 02.14.13 | 07:02 am
- FDA Approves Fulyzaq™ (Crofelemer) 125 Mg Delayed-Release Tablets For The Symptomatic Relief Of Diarrhea In Patients With HIV/AIDS On Anti-Retroviral Therapy (ART) - Business Wire 01.02.13 | 07:01 am
- Salix Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 07:01 am
- Salix Pharmaceuticals Previews The American Association For The Study Of Liver Diseases 2012 - Business Wire 11.09.12 | 07:11 am
- Salix Pharmaceuticals Reports 3Q2012 Results - Business Wire 11.07.12 | 04:11 pm
- Salix Pharmaceuticals To Present At Two Investment Conferences In November - Business Wire 11.07.12 | 07:11 am
- Salix Pharmaceuticals Announces 3Q2012 Financial Results Conference Call And Webcast - Business Wire 10.24.12 | 07:10 am
Partner Headlines for SLXP
- MIDDAY UPDATE: U.S. Equities Battle Back from Morning Downdraft: Eurozone Debt Fears Reemerge - NASDAQ 06.11.13 | 04:06 pm
- Analyst Says News of FDA Panel for Salix's Relistor Could Provide 'Another Meaningful Catalyst' - Benzinga 06.11.13 | 01:06 pm
- Positive Data on Novartis' Afinitor - Analyst Blog - Zacks 06.07.13 | 11:06 pm
- BioLineRx Enrolls First Patient in Study - Analyst Blog - Zacks 06.07.13 | 11:06 pm
- Impax Reduces Workforce - Analyst Blog - Zacks 06.07.13 | 01:06 am
- Avanir to Expedite AVP-786 Development - Analyst Blog - Zacks 06.07.13 | 12:06 am
- CHMP Positive on Novartis' Lucentis - Analyst Blog - Zacks 06.05.13 | 12:06 am
- AstraZeneca Presents Olaparib Data - Analyst Blog - Zacks 06.04.13 | 12:06 am
- Data on Merck Candidate at ASCO - Analyst Blog - Zacks 06.03.13 | 03:06 pm
- Bull of the Day: Salix Pharmaceuticals (SLXP) - Bull of the Day - Zacks 06.03.13 | 09:06 am
